The United Laboratories International Holdings Limited

SEHK:3933 Stok Raporu

Piyasa değeri: HK$19.6b

United Laboratories International Holdings Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

United Laboratories International Holdings yıllık ortalama 33.8% oranında kazançlarını artırırken, Pharmaceuticals sektöründe kazançlar growing at 5.7% annual. Gelirler growing yılda ortalama 12.6% oranında artmaktadır. United Laboratories International Holdings'in özkaynak karlılığı 21.4% ve net marjı 20.8%'dir.

Anahtar bilgiler

33.8%

Kazanç büyüme oranı

32.2%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi5.6%
Gelir büyüme oranı12.6%
Özkaynak getirisi21.4%
Net Marj20.8%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market

Oct 23
The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market

Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching

Aug 30
Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching

Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified

Feb 29
Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified

The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement

Jan 04
The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement

United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt

Dec 14
United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt

With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case

Nov 26
With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case

Is United Laboratories International Holdings (HKG:3933) A Risky Investment?

Aug 31
Is United Laboratories International Holdings (HKG:3933) A Risky Investment?

Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?

Aug 10
Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?

United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet

Dec 23
United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet

Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?

Oct 19
Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?

Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?

Aug 30
Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?

Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?

Mar 08
Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?

The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It

Feb 18
The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It

The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Feb 03
The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?

Jan 19
Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?

We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide

Jan 04
We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide

These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely

Dec 20
These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely

What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?

Dec 07
What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?

The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?

Nov 23
The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?

Gelir ve Gider Dağılımı

United Laboratories International Holdings nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SEHK:3933 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2414,0092,9082,120108
31 Mar 2413,8752,8052,25554
31 Dec 2313,7402,7012,3890
30 Sep 2313,3992,4692,47548
30 Jun 2313,0592,2362,56196
31 Mar 2312,1971,9092,45648
31 Dec 2211,3341,5812,3500
30 Sep 2210,7501,2882,37620
30 Jun 2210,1669952,40239
31 Mar 229,9359912,36820
31 Dec 219,7039882,3340
30 Sep 219,4451,0562,30420
30 Jun 219,1871,1232,27340
31 Mar 218,9809132,24820
31 Dec 208,7727032,2220
30 Sep 208,6906262,17522
30 Jun 208,6075492,12844
31 Mar 208,5005952,17222
31 Dec 198,3936422,2160
30 Sep 198,1007652,1479
30 Jun 197,8088882,07719
31 Mar 197,6597851,9589
31 Dec 187,5116831,8390
30 Sep 187,3953731,77928
30 Jun 187,280641,71956
31 Mar 187,053731,69728
31 Dec 176,827821,6750
30 Sep 176,640-341,6883
30 Jun 176,454-1501,7025
31 Mar 176,266-2111,6873
31 Dec 166,078-2721,6720
30 Sep 166,083-2161,6715
30 Jun 166,076-1591,6679
31 Mar 166,195-321,6635
31 Dec 156,446921,6950
30 Sep 156,5971481,684-12
30 Jun 156,7112011,665-23
31 Mar 156,5653731,621-12
31 Dec 146,4225451,5770
30 Sep 146,1795521,5054
30 Jun 146,1015741,4738
31 Mar 146,1123061,4524
31 Dec 135,972381,3960

Kaliteli Kazançlar: 3933 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: 3933 'nin mevcut net kar marjları (20.8%) geçen yılın (17.1%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 3933 şirketinin kazançları son 5 yılda yılda 33.8% oranında önemli ölçüde arttı.

Büyüme Hızlandırma: 3933 'un son bir yıldaki kazanç büyümesi ( 30.1% ) 5 yıllık ortalamasının ( 33.8% /yıl) altındadır.

Kazançlar vs. Sektör: 3933 geçen yılki kazanç büyümesi ( 30.1% ) Pharmaceuticals sektörünün 6.4% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: 3933 'nin Özsermaye Getirisi ( 21.4% ) yüksek olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin